width=With support from the A-T Children’s Project, the lab of Sharon McGrath-Morrow, MD, a pediatric pulmonologist for the A-T Clinical Center, is sequencing RNA from A-T patient blood cells in hopes of identifying markers that will correlate with either immune problems or cancer and predict the disease’s course. If found and validated, such biomarkers could allow researchers to confirm proof of mechanism and see efficacy more quickly during clinical trials or potentially treat specific subsets of A-T patients more precisely.

Contact Us

Related News

Jul 14 @ 7:20 am

N-Acetyl-L-Leucine Clinical Trial for A-T

IntraBio is conducting a clinical trial to test a product called N-Acetyl-L-Leucine in children and adults with A-T.

more
Jul 14 @ 7:20 am

New Edition of “Caring for People with A-T” Published

A new edition of the "Caring for People with A-T" guide has been published!

more
Jul 14 @ 7:20 am

Measles Prevention in A-T: Recommendations from Dr. Lederman

Dr. Lederman of the A-T Clinical Center provides recommendations to keep people with A-T from catching measles.

more
Jul 14 @ 7:20 am

Gene Editing for A-T Grant Awarded

We are pleased to announce that funds have been awarded to a researcher with Johns Hopkins University.

more